-
Electronic (PDF - 1 Year Sub.)
-
Electronic (Online Access)
-
Enterprisewide
-
Enterprisewide
The Pharmaceutical Market: Peru
Espicom Business Intelligence Ltd, May 2012, Pages: 58
These highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:
Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators.
Specialised intelligence on OTCs, generics, biologics and biosimilars.
Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series.
A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel.
The reports are updated quarterly, providing you with the latest information for a full year. In addition, the service will keep you up to date with market and industry news on a regular basis.
Executive Summary
THE PHARMACEUTICAL MARKET: PERU - REVIEW
Peru is often overlooked when discussing the rapid-growth economies of South America. While it has neither the size nor the wealth of Brazil or Argentina, the country has a population that exceeded 30 million in 2011, and has recorded strong economic growth in recent years. According to the Economist Intelligence Unit (EIU), GDP increased by 6.5% in real terms in 2011. GDP per capita has risen, especially around Lima, leading to a sizeable urban population that demands improved healthcare and has the ability to pay for it. This economic environment is expected to encourage drug consumption. In legal terms, Peru is continuing to implement its National Strategic Plan to combat counterfeiting and piracy.
The Peruvian pharmaceutical market is the second smallest in the region. The market is expected to increase by a moderate CAGR in dollar terms between 2011 and 2016. Pharmaceutical expenditure per capita is the lowest in the region. This means that there are growth opportunities, as the economy is expected to perform well in the forecast period. The market increased five times between 1995 and 2010. In January 2011, the Israeli company Teva Pharmaceutical Industries announced that it was acquiring Infarmasa from The Rohatyn Group (TRG) and Altra Investments. Teva commented that the combination of Medco, which was Teva’s existing operation in Peru, and Infarmasa would create one of the top two pharmaceutical companies in the country.
Major Peruvian pharmaceutical wholesalers include Química Suiza, Albis and Drokasa. Química Suiza imports, produces, markets and distributes pharmaceuticals, personal care products and equipment for the industrial sector. The company has offices in Arequipa, Chiclayo, Cusco, Huancayo, Iquitos, Lima, Piura and Trujillo. Química Suiza also has a regional presence, with subsidiaries in Bolivia, Colombia, Ecuador and Venezuela. The company has six divisions. In February 2011, Química Suiza acquired the pharmacy chain Boticas BTL for an undisclosed transaction value. With this acquisition, Química Suiza will control about 300 pharmacies in Peru; the company already owns Boticas Mifarma in the retail pharmacy sector.
ENHANCED STRATEGIC INTELLIGENCE
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:
Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators.
Specialised intelligence on OTCs, generics, biologics and biosimilars.
Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series.
A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel.
The reports are updated quarterly, providing you with the latest information for a full year. In addition, the service will keep you up to date with market and industry news on a regular basis.
HEALTHCARE STATISTICS
A comprehensive tabula review, comprising demographics, epidemiology, health expenditure, hospital and primary care infrastructure & services and healthcare personnel, is additionally included.
Related Pages
Pharmaceutical Market Mexico
Pharmaceutical Market USA
More Information...
HIGHLY DETAILED REPORT CONTENT
EXECUTIVE SUMMARY
Including Espicom's at a glance strategic analysis and key data projections
MACROENVIRONMENT
Political, economic, legal and demographic analysis
EPIDEMIOLOGY
Disease burden and prevalence
HEALTHCARE
Organisation, expenditure, infrastructure, services and workforce
REGULATORY AFFAIRS
Regulatory developments and marketing registration/authorisation
PRICING & REIMBURSEMENT
DISTRIBUTION CHANNELS
MARKET ANALYSIS
Projections, product development, manufacturing and trade
COMPETITION
Trade associations, trade fairs, company intelligence and competitive strategies
OTC PHARMACEUTICALS
GENERIC PHARMACEUTICALS
BIOLOGICS & BIOSIMILARS
OPPORTUNITIES & CHALLENGES
Espicom's unique strategic analysis
DIRECTORY
METHODOLOGY & SOURCES
EXECUTIVE SUMMARY
Snapshot: Strategic Espicom Analysis
Snapshot: Key Data Projections
MACROENVIRONMENT POLITICAL ECONOMIC
Projections
LEGAL
Consumer Rights
Drug Counterfeiting
Intellectual Property Rights
DEMOGRAPHIC
Projections
Demographic Indicators
Birth Rate
Death Rate
Infant Mortality Rate
Life Expectancy at Birth
EPIDEMIOLOGY
DISEASE BURDEN
DISEASE PREVALENCE
Communicable Diseases Dengue HIV/AIDS Malaria Tuberculosis
Non-Communicable Diseases
HEALTHCARE - ACCOMPANYING HEALTH STATISTICS
ORGANISATION
Public Providers
ESSALUD
FFAA
MINSA PNP
Non-Public Providers .
AID PROJECTS
WB
Results & Accountability (REACT) Development Policy Loan (DPL)
Health Reform Programme
IADB
Health Reform Programme
EXPENDITURE
Projections
Health Insurance
AUS
INFRASTRUCTURE SERVICES
Inpatient Services
Outpatient Services
WORKFORCE
Projections
REGULATORY AFFAIRS
REGIONAL REGULATION
ORAS – CONHU
NATIONAL REGULATION
Drug Approval Process
Advertising
PRICING & REIMBURSEMENT PRICING
Regional Activities
ORAS – CONHU
National Activities
Public Procurement
Public Monitoring
REIMBURSEMENT
PNUM
Reimbursement
DISTRIBUTION CHANNELS
WHOLESALING
Leading Wholesalers
Albis Drokasa
Química Suiza
RETAILING
Trade Association
ANACAB
Leading Pharmacy Chains
Arcángel
BTL ByS
Fasa Inkafarma
Mifarma
Wong
MARKET ANALYSIS SIZE
Projections
Historical Figures Structure
Private Pharmacy Sales
Public Sales
PRODUCT DEVELOPMENT
PRODUCTION TRADE
Exports
Imports
Balance of Trade
COMPETITION
TRADE ASSOCIATIONS ADIFAN
ALAFAL ALAFARPE
COMSALUD
COMPANY INTELLIGENCE
Local Producers
AC Farma
Farmindustria
Gianfarma Hersil
Induquímica
Infarmasa
IQFARMA
Medco Medifarma
Refasa
Roxfarma
Competitive Strategies
CONCLUSIONS: OPPORTUNITIES & CHALLENGES
Strategic Espicom Analysis
MACROENVIRONMENT
EPIDEMIOLOGY
HEALTHCARE
REGULATORY AFFAIRS
PRICING & REIMBURSEMENT
DISTRIBUTION CHANNELS
MARKET
COMPETITION
OTC PHARMACEUTICALS
GENERIC PHARMACEUTICALS
BIOLOGICS & BIOSIMILARS
Radar Analysis
SWOT Analysis
DIRECTORY
COMPANY INTELLIGENCE
Local Producers
GOVERNMENT ORGANISATIONS
TRADE ASSOCIATIONS
List of tables
Espicom Analysis of the Pharmaceutical Market, 2011
Key Data Projections, 2011-2016
Political Landscape, 2011
Regional Ranking of Projected Economies, 2016
Projected Economy, 2011-2016
Regional Ranking of Projected Demographics, 2016
Projected Demographics, 2011-2016
Selected Causes of Death by Sex, 2010
MINSA’s Departments, 2011
MINSA’s Decentralised Institutions & Institutes, 2011
MINSA’s DISAs & DIRESAs, 2011
Regional Ranking of Projected Health Expenditure, 2016
Projected Health Expenditure, 2011-2016
Infrastructure, 2004-2009
Regional Ranking of Projected Physicians, 2016
Projected Physicians, 2011-2016
Public Procurement of Pharmaceuticals by Provider, 2007-2009 (Million Soles)
Albis Distribution’s Pharmaceutical Lines, 2011
Members of ANACAB, 2011
Regional Ranking of Projected Pharmaceutical Markets at Retail Prices, 2016
Projected Pharmaceutical Market at Retail Prices, 2011-2016
Historical Pharmaceutical Market at Retail Prices, 1995-2010
Domestic Production, 1992-2009
GMP Certificates, January-December 2010
Pharmaceutical Exports by Category, 2005-2009 (US$000s)
Pharmaceutical Exports by Country/Region, 2009 (US$000s)
Exporters of Medicinal & Pharmaceutical Products, 2010
Pharmaceutical Imports by Category, 2005-2009 (US$000s)
Imports of Raw Materials by Country/Region, 2009 (US$000s)
Imports of Antisera & Vaccines by Country/Region, 2009 (US$000s)
Imports of Medicaments by Country/Region, 2009 (US$000s)
Pharmaceutical Balance of Trade, 2005-2009 (US$000s)
Members of ADIFAN, 2011
Members of ALAFARPE, 2011
Members of COMSALUD, 2011
Espicom Analysis of the Pharmaceutical Market, 2011
SWOT Analysis of the Pharmaceutical Market, 2011
List of Charts
Regional Comparison of Top 5-10 Projected Pharmaceutical Markets at Retail Prices, 2016
Regional Comparison of Projected Pharmaceutical Market Share at Retail Prices, 2016
Historical Pharmaceutical Market at Retail Prices, 1995-2010
Domestic Production, 1992-2009 (Million Pesos)
Domestic Production, 1992-2009 (US$ Million)
Pharmaceutical Exports, 2000-2009 (US$ Millions)
Pharmaceutical Imports, 2000-2009 (US$ Millions)
Pharmaceutical Imports by Country/Region, 2009 (%)
Pharmaceutical Balance of Trade, 2000-2009 (US$ Millions)
Radar Graph of the Pharmaceutical Market, 2011
- Química Suiza
- Albis
- Drokasa
- ADIFAN
- ALAFARPE
- Farmindustria
- Hersil
- Induquímica
- Infarmasa Corporation
- Medco Corporation
- Medifarma
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
